Allergy and Immunization CME

  • FEATURED

    The Brigham Board Review in Allergy and Immunology

    This Allergy and Immunology CME course will help you learn the latest strategies for managing allergic and immunologic disorders as you prepare for your ABIM exams.

    Topics covered include:

      • T cells and Innate Lymphoid Cells
      • Mucosal Immunity and the Microbiome
      • Diagnosis and Management of Asthma
      • Mast Cell Biology
      • Food Allergy
      • <//ul>

    After completing this course, you will better be able to:

      • Integrate and demonstrate improved understanding of allergic/immunologic disorders
      • Identify and improve clinical competence-based practice gaps in allergy/immunology
      • Correlate pathophysiology and pathobiologic principles with clinical presentations
      • Stay updated on an expanding array of therapeutic options, their risks and benefits
      • Prepare for ABIM certification/recertification examinations
      • Integrate the knowledge gained into daily practice and provide utmost level of care to your patients

    Target Audience: Fellows/trainees and practicing allergists/immunologists and other professional affiliates, such as internists, with an interest in Allergy/Immunology or who seek CME in attempt to improve patient care.

    See full details chevron_right
    • Cost: $695
    • Credit hours: 27.5
    • CME credits awarded by: Oakstone Publishing, LLC
    • Format: On-Demand Online, Online Video, Online Audio, Audio CD
    • Material last updated: December 31, 2018
    • Expiration of CME credit: December 31, 2021
  • FREE

    ScientiaCME Immunology – Allergy CME

    • Cost: Free
    • Credit hours: 3
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Expiration of CME credit: Two years after release
  • FREE

    ScientiaCME Immunology (Kidney Transplant Rejection)

    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Expiration of CME credit: Two years after release
  • FREE

    Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy

    Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy emphasizes the use of IVIg in the treatment of Chronic Inflammatory Demyelinating Polyneuropathy.

    The presentation consists of a single lecture, Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy, with discussion by Roy L. Freeman, MD, Richard J. Barohn, MD and Kenneth C. Gorson, MD.

    After viewing Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy, you will be better able to :
    • Conduct a thorough and timely evaluation and differential diagnosis of patients with chronic inflammatory demyelinating polyneuropathy.
    • Devise appropriate treatment regimen for the effective management of chronic inflammatory polyneuropathy based on guidelines and clinical evidence.

    Target Audiences:
    This program is intended for US-based neurologists, immunologists, physician assistants, nurse practitioners, and nurses who manage, or have an interest in managing patients with immune-mediated neuropathies.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: Postgraduate Institute for Medicine
    • Format: On-Demand Online, Online Video
    • Material last updated: July 27, 2017
    • Expiration of CME credit: July 27, 2018
  • FREE

    Journal of Allergy and Clinical Immunology (JACI) Online CME Program

    Some popular articles and quizzes include:
    • Gene-environment interactions in asthma and allergic diseases
    • Allergy to B-lactam antibiotics
    • Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species
    • Cutaneous drug reactions
    • IL-13 in asthma and allergic disease: Asthma phenotypes and targeted therapies
    • Evaluation and management of a patient with chronic pruritus
    • Human versus mouse eosinophils

    Target Audience: Physicians focusing on Allergy, Chest Medicine

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1 Credit per article/quiz
    • CME credits awarded by: AAAAI
    • Format: On-Demand Online
  • FREE

    Medscape Allergy and Immunology

    CME activities of special interest to allergists and immunologists. Medscape contains a variety of educational formats:

    CONFERENCE COVERAGE – Reports of advances presented at major medical conferences; typically includes several tracks with news stories, expert interviews, and in-depth topic overviews.

    CLINICAL UPDATE – Comprehensive original review article on scientific advances in a clinical topic.

    FAST TRACK CLINICAL UPDATE – Narrowly focused original review article on scientific advances in a clinical topic.

    CME-LIVE – Real-time online events with streaming video, synchronized visuals, and interactive questions and answers; archived for 1 year.
    CLINICAL BRIEFS – Daily reports of major current medical research articles; 0.25 credits each

    JOURNAL CME – Articles selected from a wide selection of peer-reviewed journals.
    SPECIAL REPORT CME – Topic-based monthly email newsletter distributed to Medscape’s professional member database by specialty.

    INTERACTIVE PATIENT CASES – Original CME activity presented to the physician in an interactive, clinical case-based format. (See especially eMedicine CME Case Presentations.)

    CME CIRCLE – Multimedia content certified by other accredited professional education providers, typically from live symposia or monographs, and then posted on Medscape and archived for one year.

    Target Audience: ALLG

    See full details chevron_right
    • Cost: Free
    • Credit hours: Varies depending on course
    • CME credits awarded by: Medscape and many other sponsoring organizations.
    • Format: On-Demand Online
    • Material last updated: Continuously Updated
  • FREE

    CME: Hereditary angioedema (HAE): optimizing treatment strategies

    Hereditary angioedema (HAE) is a rare, debilitating, and potentially life-threatening disease due to C1-inhibitor (C1-INH) deficiency with an estimated frequency of 1 in 50,000 people. HAE is characterized by recurrent edema attacks and the cutaneous attacks can be disabling, with the skin, gastrointestinal tract, and upper airways are most commonly affected and with a persistent risk to the patient of acute events of laryngeal swelling that may prove fatal if not treated in a timely manner. Angioedema in general can be confused with cellulitis, Graves’ disease, blepharochalasis, eosinophilic fasciitis, or amyloidosis which can lead to delays in diagnosis, and inappropriate treatment poses the risk of adverse events, unnecessary surgical interventions, a higher burden of misery, and a potentially higher rate of morbidity and mortality.

    By the end of the session the participant will be able to:

    • Recall the pathophysiology of HAE such that it might inform treatment mechanisms
    • Recognize the risks associated with misdiagnosis of HAE
    • Evaluate a treatment plan for a patient with HAE designed to optimize safety and efficacy, suggesting modifications for improvement
    • Describe present and emerging drug therapies for management of HAE and apply them to patient cases taking into account the patient’s history or anticipated place in therapy

    Target Audience:

    Healthcare professionals who are: allergists, immunologists, and internists; physician assistants, nurse practitioners, nurses, and pharmacists specializing in immunology; and any other HCPs who have an interest in or otherwise clinically encounter patients with HAE.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 3/23/2020
    • Expiration of CME credit: 3/23/2022
  • FREE

    CME: Cold agglutinin disease (CAD): Updates from the American Society of Hematology (ASH) 2019 annual meeting

    Cold agglutinin disease (CAD) is a subtype of autoimmune hemolytic anemia (AIHA) and characterized by cold agglutinin (CA) autoantibodies that cause the erythrocytic hemolysis. Also known as primary or idiopathic CAD, it is distinguished further from cold agglutinin syndrome (CAS), which is a complication of known conditions such as malignancy, infection, or autoimmune disease. Little is known about the epidemiology of CAD; one small study estimated incidence of 1 per 1 million people and prevalence of 1 per 16 million people with females twice as likely males to develop the disease and a median age of onset of 67 years.

    By the end of the session the participant will be able to:

    • Describe the pathogenesis and symptomology of AIHA generally and CAD specifically
    • Describe how diagnosis of CAD is distinguished from other subtypes of AIHA and challenges to successful identification of patients
    • Describe present and emerging treatment options for CAD and monitoring parameters for effectiveness of treatment
    • Develop a safe and clinically effective treatment plan including non-pharmacologic and pharmacologic therapy for patients with CAD

    Target Audience:

    The following healthcare professionals (HCPs): hematologists, oncologists, immunologists; physician assistants, nurse practitioners, and pharmacists who practice in the aforementioned areas of specialty; and any other HCPs with an interest in or who clinically encounter patients with CAD.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 2/21/2020
    • Expiration of CME credit: 2/21/2021
  • FREE

    CME: Medical and nutritional management of eosinophilic esophagitis in adolescents and adults: therapeutic updates and best practices

    Eosinophilic esophagitis (EoE) is a chronic immune-mediated disease characterized by clinical features of esophageal dysfunction and eosinophil inflammation. EoE is mediated by type 2 helper T cell activity and precipitated primarily by dietary antigens. It may affect people of all ages and races, but the prevalence is highest amongst middle-aged Caucasian males. Approximately 30 out of every 100,000 adults in the U.S. are thought to have the condition.

    By the end of the session the participant will be able to:

    • Describe the patholophysiology of EoE in adults and adolescents such that it informs treatment mechanisms
    • Describe the clinical presentation, complications associated with, and diagnosis EoE in adults and adolescents.
    • Identify current drug treatment options and dietary strategies available for the management of EoE, including strengths and weaknesses of each, and apply them to patient cases using evidence-based medicine.
    • Identify issues with current practices for EoE and strategies to address them.

    Target Audience:

    The following healthcare professionals: allergists, immunologists, pediatricians, and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who specialize in the aforementioned fields; and any other healthcare professionals with an interest in or who may clinically encounter patients with EoE.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 2/15/2020
    • Expiration of CME credit: 2/15/2022